Stock Groups

3 Psychedelics Stocks Wall Street Predicts Will Soar -Breaking

by Mike Robinson

[ad_1]

© Reuters. Wall Street Forecasts 3 Psychoedelics Stocks Will Soar

Patients with neurological and/or psychiatric disorders can be treated by psychedelic drugs like MDMA or psilocybin. This is why drug companies that specialize in developing drugs are becoming more interested. Given the industry’s growth potential, Wall Street analysts expect stocks in this space—MindMed (MNMD), Cybin (CYBN), and Field Trip Health (FTRP)—to soar in price. So, let’s take a closer look at these names.Psychedelics are drugs that have a psychotropic effect on the senses. These substances can either be made from natural materials or manufactured in labs and have been widely used as treatment for mental illness. Psychedelics, such as “magic mushrooms” and MDMA are being used to treat patients with post-traumatic stress disorder (PTSD), depression, and substance addiction. Federal funding for a study on psilocybin to treat tobacco addiction was approved last month. This indicates that the drug is being considered as a possible medication.

In the recent years drug companies have scrambled to obtain authoritative approval for MDMA or psilocybin. They are disruptors of the nervous system disorder treatment industry. This sector also seeks to create new jobs.

A Data Bridge research report states that the global psychedelic drugs industry is set to expand at a 13.3% rate to $7.57 million in 2028. Considering the industry’s growth potential, Wall Street analysts expect psychedelic stocks Mind Medicine (MindMed) Inc. (MNMD), Cybin Inc. (CYBNField Trip Health Ltd.FTRP) to deliver major gains.

Continue reading on StockNews

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses caused by the data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of the potential risks and financial costs involved in trading the financial market. It is one the most dangerous investment types.

[ad_2]